SLC6A3 and attention deficit-hyperactivity disorder: Potential upregulation of dopamine transporters after long-term MPH treatment is discussed to be associated with an increase in ADHD symptoms while not taking medication.37 However, in our study, ADHD symptoms remained improved and stable for 1.5 years after termination of controlled treatment.